The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus

Abstract Background Guidelines classify sacubitril/valsartan as a significant part of medical treatment of heart failure with reduced ejection fraction (HFrEF). Data have shown that the HbA1c levels in patients with diabetes mellitus could be impacted by sacubitril/valsartan. A possible positive eff...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ibrahim El‐Battrawy, Jonathan Demmer, Mohammad Abumayyaleh, Carina Crack, Christina Pilsinger, Xiaobo Zhou, Andreas Mügge, Ibrahim Akin, Assem Aweimer
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Oxford University Press 2023-04-01
סדרה:	ESC Heart Failure
נושאים:	Life‐threatening arrhythmia Sacubitril/valsartan Sudden cardiac death Diabetes mellitus
גישה מקוונת:	https://doi.org/10.1002/ehf2.14239
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!